Many users report feeling an improvement in energy levels and a reduction in symptoms like nerve pain or tingling within a few days to a week of starting treatment, depending on the severity of their deficiency or condition
Importantly, initiation of GLP-1RA may decrease levothyroxine dose requirements in patients with hypothyroidism through weight loss, enhance levothyroxine absorption due to delayed gastrointestinal (GI) transit, and have direct effects on the hypothalamic-pituitary-thyroid axis [23,24,25,26,27,28,29], potentially increasing the risk of thyroid hormone over-replacement (i.e., iatrogenic hyperthyroidism)
405 RossiM.CarusoF.AntoniolettiR.VigliantiA.TraversiG.LeoneS.et al (2013)
For doses requiring fractional units (e.g., 7.5 units), round to the nearest whole unit or use a higher reconstitution volume for easier measurement
Exercise plus GLP-1 medication produces approximately 40% more weight loss, twice the body fat reduction, and improvements in fitness, blood sugar, insulin sensitivity, and bone health that medication alone cannot achieve
Semaglutide and other GLP-1 medications trigger nausea in roughly 25-40% of users, especially after meals, because they mimic a natural gut hormone that slows digestion and reduces appetite
